Tags

Type your tag names separated by a space and hit enter

Alemtuzumab-induced halo naevus-like hypopigmentation - new insights into secondary skin autoimmunity in response to an immune cell-depleting antibody.
J Eur Acad Dermatol Venereol. 2020 Jun 24 [Online ahead of print]JE

Authors+Show Affiliations

Department of Dermatology, University of Münster, Münster, Germany.Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.Department of Dermatology, University of Münster, Münster, Germany.Department of Dermatology, University of Münster, Münster, Germany.Department of Dermatology, University of Münster, Münster, Germany.Department of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, The Netherlands.Clinic of Neurology with Institute for Translational Neurology, University of Münster, Münster, Germany.

Pub Type(s)

Letter

Language

eng

PubMed ID

32579750

Citation

Böhm, M, et al. "Alemtuzumab-induced Halo Naevus-like Hypopigmentation - New Insights Into Secondary Skin Autoimmunity in Response to an Immune Cell-depleting Antibody." Journal of the European Academy of Dermatology and Venereology : JEADV, 2020.
Böhm M, Kemp EH, Metze D, et al. Alemtuzumab-induced halo naevus-like hypopigmentation - new insights into secondary skin autoimmunity in response to an immune cell-depleting antibody. J Eur Acad Dermatol Venereol. 2020.
Böhm, M., Kemp, E. H., Metze, D., Muresan, A. M., Neufeld, M., Luiten, R. M., & Ruck, T. (2020). Alemtuzumab-induced halo naevus-like hypopigmentation - new insights into secondary skin autoimmunity in response to an immune cell-depleting antibody. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.16781
Böhm M, et al. Alemtuzumab-induced Halo Naevus-like Hypopigmentation - New Insights Into Secondary Skin Autoimmunity in Response to an Immune Cell-depleting Antibody. J Eur Acad Dermatol Venereol. 2020 Jun 24; PubMed PMID: 32579750.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Alemtuzumab-induced halo naevus-like hypopigmentation - new insights into secondary skin autoimmunity in response to an immune cell-depleting antibody. AU - Böhm,M, AU - Kemp,E H, AU - Metze,D, AU - Muresan,A M, AU - Neufeld,M, AU - Luiten,R M, AU - Ruck,T, Y1 - 2020/06/24/ PY - 2020/03/31/received PY - 2020/06/03/revised PY - 2020/06/16/accepted PY - 2020/6/25/pubmed PY - 2020/6/25/medline PY - 2020/6/25/entrez JF - Journal of the European Academy of Dermatology and Venereology : JEADV JO - J Eur Acad Dermatol Venereol SN - 1468-3083 UR - https://www.unboundmedicine.com/medline/citation/32579750/Alemtuzumab-induced_halo_nevus-like_hypopigmentation_-:_New_insights_into_secondary_skin_autoimmunity_in_response_to_an_immune_cell-depleting_antibody L2 - https://doi.org/10.1111/jdv.16781 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.